Comments on:

RI gets $1.2M in diabetes drug settlement

Back to the article » |
PROVIDENCE, R.I. (AP) — Rhode Island is getting about $1.2 million to settle claims that British drug maker GlaxoSmithKline deceptively promoted the diabetes drug Avandia. The payment is part of a $90 million settlement between GlaxoSmithKline and attorneys general from 38 different states. Attorney General Peter Kilmartin and colleagues claim the company misrepresented Avandia's...